Reports & Articles

Articles (2010-2017)


  1. Cousins, Sarah J., Desirée Crèvecoeur-MacPhail, Tina Kim, and Richard A. Rawson. "The Los Angeles County hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in Los Angeles County (2010–2015)." Journal of Substance Abuse Treatment (2017).
  2. Cousins, S. J., Radfar, S. R., Crèvecoeur-MacPhail, D., Ang, A., Darfler, K., & Rawson, R. A. (2016). Predictors of continued use of extended-released naltrexone (XR-NTX) for opioid-dependence: an analysis of heroin and non-heroin opioid users in Los Angeles County. Journal of substance abuse treatment63, 66-71.
  3. Herbeck, D. M., Jeter, K. E., Cousins, S. J., Abdelmaksoud, R., & Crèvecoeur-MacPhail, D. (2016). Gender differences in treatment and clinical characteristics among patients receiving extended release naltrexone. Journal of addictive diseases35(4), 305-314.
  4. Cousins, S. J., Denering, L., Crèvecoeur-MacPhail, D., Viernes, J., Sugita, W., Barger, J. & Rawson, R. A. (2016). A demonstration project implementing extended-release naltrexone in Los Angeles County. Substance abuse37(1), 54-62.
  5. Crevecoeur-MacPhail, D. A., Cousins, S. J., Barger, J., Bennett, D., Vasquez, E., Sugita, W., & Rawson, R. (2015). Do medications impact treatment outcomes? XR-NTX in county-funded treatment. Drug & Alcohol Dependence146, e252. DOI:
  6. Crèvecoeur-MacPhail, D. A. (2015). Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users. Addiction science & clinical practice10(1), A9.
  7. Denering, L. L., Crevecoeur-MacPhail, D. A., Dickerson, D., & Rawson, R. (2014). Telepsychiatry for patients with co-morbid psychiatric and substance use disorders: A UCLA integrated substance abuse programs (ISAP) and Los Angeles County Department of Public Health–Substance Abuse, Prevention, and Control (SAPC) pilot. Drug & Alcohol Dependence140, e47. DOI:
  8. Crevecoeur-MacPhail, D. A., Rawson, R., Counsins, S. J., & Denering, L. L. (2014). The impact of Vivitrol on short-term outcomes post-medication. Drug & Alcohol Dependence140, e40-e41. DOI:
  9. Spear, S. E., Crevecoeur-MacPhail, D., Denering, L., Dickerson, D., & Brecht, M. (2013). Determinants of successful treatment outcomes among a sample of urban American Indians/Alaska Natives: The role of social environments. The Journal of Behavioral Health Services & Research, doi:
  10. Crèvecoeur-MacPhail, D., Ransom, L., Myers, A. C., Annon, J. J., Diep, N., Gonzales, R., Rawson, R.A., Viernes, J., Sugita, W., and Barger, J. (2010). Inside the black box: Measuring addiction treatment services and their relation to outcomes. Journal of psychoactive drugs, 42(sup6), 269-276.
  11. Padwa, H., Larkins, S., Crevecoeur-MacPhail, D. A., & Grella, C. E. (2013).  Dual diagnosis capability in mental health and substance use disorder treatment programs.  Journal of Dual Diagnosis, 9(2), 179-186.
  12. Rutkowski, B., Gallon, S., Rawson, R. A., Freese, T. E., Bruehl, A., Crèvecoeur-MacPhail, D., Sugita, W., Molfenter, T.,  & Cotter, F (2010). Improving client engagement and retention in treatment: The Los Angeles County experience. Journal of Substance Abuse Treatment, 39, 78–86.
  13. Rawson, R., Gonzales, R., Crèvecoeur-MacPhail, D., Urada, D., Brecht, ML., Chalk, M., Kemp, J., & Cunningham, M. (2010). Improving the Accountability of California’s Public Substance Abuse Treatment System. Journal of Psychoactive Drugs, SARC Supplement 6, 211-214.
  14. Padwa, H., Urada, D., Antonini, V. P., Ober, A., Crevecoeur-MacPhail, D., & Rawson, R. A. (2012).  Integrating substance use disorder services with primary care: The experience in California.  Journal of Psychoactive Drugs, 44(4), 299-306.  doi:
  15. Crèvecoeur-MacPhail, D., Bellows, A., Rutkowski, B. A., Ransom, L., Myers, A. C., & Rawson, R. A. (2010). "I've been NIATxed": Participants' Experience with Process Improvement. Journal of psychoactive drugs42(sup6), 249-259.
  16. Urada, D., Schaper, E., Alvarez, L., Reilly, C., Dawar, M., Field, R., Rawson, R. A. (2012). Perceptions of mental health and substance use disorder services integration among the workforce in primary care settings.Journal of Psychoactive Drugs, 44(4), 292-298. doi:




The Impact of Telepsychiatry for Patients with Co-morbid Disorders at a Rural County-Run Residential Treatment Clinic
Addiction Health Services Research Conference, Portland OR, October 2013


XR-NTX Implementation in Los Angeles County, October 2013


Implementation of Antagonist Medication into SUD Treatment System
Department of Health Care Services, SUD Statewide Conference, Costa Mesa, CA, August 2014




Crèvecoeur-MacPhail, D. Addiction Medications. (2012).  In Salem Health: Addictions & Substance Abuse. Pasadena: Salem Press, Inc.

Crèvecoeur-MacPhail, D. Naltrxone. (2012).  In Salem Health: Addictions & Substance Abuse. Pasadena: Salem Press, Inc. Pasadena: Salem Press, Inc.

Crèvecoeur-MacPhail, D. Health Disparities and Substance Abuse. (2012).  In Salem Health: Addictions & Substance Abuse. Pasadena: Salem Press, Inc.


Crèvecoeur-MacPhail, D., Gonzales, R., Rawson, R., Fielding, J. E., & Viernes, J. (2012). Making Decisions in Substance Abuse Treatment: The Development of Performance Measurement. In Fielding, J. & Teutsch S. (Eds.), Public Health in Practice:  Lessons from the Nation’s Largest, Most Diverse County.